Low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke

Completed

Phase N/A Results

Summary of Purpose

To compare the effect of LMW heparin to that of placebo in the prevention of deep vein thrombosis (DVT) in acute ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 October 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Prospective, double-blind, randomized, placebo-controlled trial of 103 patients.

Contacts

Not available